ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

CCCC C4 Therapeutics Inc

6,16
-0,64 (-9,41%)
10 Mai 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
C4 Therapeutics Inc CCCC NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
-0,64 -9,41% 6,16 21:00:00
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
6,85 6,15 6,935 6,16 6,80
mais cotações »

Notícias Recentes

Data Hora Fonte Título
08/05/202408:00GLOBEC4 Therapeutics Reports First Quarter 2024 Financial Results..
29/04/202417:01GLOBEC4 Therapeutics Announces Inducement Grant Under Nasdaq..
09/04/202408:00GLOBEC4 Therapeutics to Participate in the Stifel 2024 Targeted..
08/04/202409:00GLOBEC4 Therapeutics Presents New Preclinical Data for CFT1946..
05/03/202418:30GLOBEC4 Therapeutics to Present New Preclinical Data on Highly..
04/03/202409:00GLOBEC4 Therapeutics Announces Strategic Discovery Research..
22/02/202409:00GLOBEC4 Therapeutics Reports Fourth Quarter and Full Year 2023..
09/01/202418:01GLOBEC4 Therapeutics Announces 2024 Priorities and Extended Cash..
04/01/202418:01GLOBEC4 Therapeutics Announces Closing of $25 Million Equity..
04/01/202409:00GLOBEC4 Therapeutics to Present at the 42nd Annual J.P. Morgan..
12/12/202318:01GLOBEC4 Therapeutics Announces Positive Data from CFT7455 Phase 1..
12/12/202311:15APSBiotech Catches Major Premarket Bid
12/12/202309:00GLOBEC4 Therapeutics Announces License and Research Collaboration..
28/11/202309:00GLOBEC4 Therapeutics to Host Webcast to Present New Dose..
20/11/202309:00GLOBEC4 Therapeutics Strengthens Board of Directors with Owen..
01/11/202308:00GLOBEC4 Therapeutics Reports Third Quarter 2023 Financial Results..
11/10/202308:00GLOBEC4 Therapeutics Announces Upcoming Data Presentations for..
05/09/202317:01GLOBEC4 Therapeutics Announces Chief Financial Officer Succession
08/08/202308:00GLOBEC4 Therapeutics Reports Second Quarter 2023 Financial..
17/07/202308:00GLOBEC4 Therapeutics Announces Inducement Grants Under Nasdaq..
05/07/202311:30DJNC4 Therapeutics Shares Up 18% After Lung Cancer Drug..
05/07/202308:00GLOBEC4 Therapeutics Announces FDA Clearance of Investigational..
20/06/202308:00GLOBEC4 Therapeutics Appoints Leonard Reyno, M.D., as Chief..
30/05/202308:00GLOBEC4 Therapeutics and Betta Pharmaceuticals Announce Exclusive..

Seu Histórico Recente

Delayed Upgrade Clock